熱門資訊> 正文
Bone Biologics将通过行使认购权筹集210万美元
2024-08-02 20:44
- Bone Biologics (NASDAQ:BBLG) said it will exercise of certain existing warrants to purchase an aggregate of 781.3K shares having an exercise price of $2.43 apiece.
- The gross proceeds from the exercise of the existing warrants and the issuance of new warrants are expected to be ~$2.1 million.
- The company will issue new unregistered warrants to purchase up to an aggregate of 1.6M shares.
- The new warrants will be immediately exercisable at an exercise price of $2.00 per share.
More on Bone Biologics
- Seeking Alpha’s Quant Rating on Bone Biologics
- Historical earnings data for Bone Biologics
- Financial information for Bone Biologics
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
